November 02, 2025

Get In Touch

J-K Records 97 Per Cent Immunization In Measles-Rubella Vaccination Drive: Govt

Jammu: Jammu and Kashmir has recorded a 97 per cent immunization of children in the age group of 0.9 to 15 years under the ongoing measles-rubella (MR) vaccination campaign, an official spokesman said Tuesday.

The campaign which was launched in the state on September 24 has already achieved 99 per cent immunization in Kashmir division and 94 per cent in Jammu division which is almost 97 per cent of the set target for the state, the spokesman said.

The figures were conveyed by the Principal Secretary, Health and Medical Education, Atal Dulloo in a meeting to review the status of targets achieved under the campaign.

Expressing concern over a little low performance of the campaign in Shopian in south Kashmir and Poonch, Rajouri and Reasi districts in Jammu, Dulloo asked the concerned officers to further gear up their teams to achieve the set targets.

The campaign would continue till December 15 to meet per cent target, Dulloo said and made a fervent appeal to all to get their wards vaccinated under this programme free of cost.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!